HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Oncology
Meta-analysis
Qigong shows large effect on subjective cognitive function in cancer survivors in meta-analysis
Can gentle movement help cancer survivors struggling with brain fog?
A systematic review and meta-analysis of 16 studies in cancer survivors found qigong significantly improved subjective cognitive function ve…
Cancer survivors struggling with brain fog may feel clearer after practicing qigong, a gentle mix of movement and breathing that showed stro…
Apr 5, 2026
Oncology
RCT
Interactive e-books and traditional education show comparable effectiveness for foundational cancer sleep management nurse training
Study compares e-book and traditional training for nurses on cancer sleep management
A cluster randomized controlled trial of 142 oncology nurses found both interactive e-books and traditional education significantly improved…
Interactive e-books and traditional classes both boosted nurses' confidence in helping cancer patients with sleep issues, though knowledge g…
Apr 5, 2026
Genetics & Precision Medicine
Sys. Review
Systematic review finds first FDA-approved CRISPR therapy and broader clinical trial exploration
First CRISPR gene therapy approved for blood disorders, with broader research underway
A systematic review of clinical trials registered at clinicaltrials.gov found the first CRISPR-Cas9 therapy obtained FDA approval in late 20…
The first CRISPR gene therapy is approved for sickle-cell anemia and β-thalassemia, with ongoing trials exploring its use for cancer and inf…
Frontiers
Apr 3, 2026
Genetics & Precision Medicine
Sys. Review
Review examines reference gene selection methods for qRT-PCR normalization in cancer research
Review examines gene analysis methods for cancer research and precision medicine
A systematic review describes the progression of traditional and advanced reference gene selection methods for qRT-PCR normalization and the…
Accurate cancer research depends on picking the right reference genes, and new tools now help scientists choose them for better precision me…
Frontiers
Apr 3, 2026
Cardiology
Meta-analysis
Catheter ablation for atrial fibrillation in cancer patients shows non-significant bleeding trend
Catheter ablation for atrial fibrillation shows similar outcomes in cancer and non-cancer patients
A meta-analysis of 69,819 patients from eight observational studies compared catheter ablation outcomes in atrial fibrillation patients with…
Catheter ablation for atrial fibrillation works similarly in cancer and non-cancer patients, with a trend toward more bleeding in cancer sur…
Apr 2, 2026
Oncology
Phase I
Modeling study predicts human pharmacokinetics for TAK-500, an anti-CCR2 antibody-drug conjugate
Early modeling study predicts how a new cancer drug candidate might behave in humans
A preclinical and clinical modeling study used cynomolgus monkey data and human parental antibody data to simulate human pharmacokinetics fo…
A computer model predicts that a new cancer drug stays in the body longer as the dose increases, helping scientists plan safe first-in-human…
Apr 2, 2026
Cardiology
COVID-19 was the third leading cause of death in the United States in 2021
COVID-19 was the third leading cause of death in the United States in 2021
A 2021 U.S. mortality data report indicates COVID-19 was the third leading cause of death, following heart disease and cancer.
In 2021, COVID-19 remained the third leading cause of death in the United States, trailing only heart disease and cancer.
CDC
Apr 2, 2026
Allergy & Immunology
Sys. Review
Review explores mitochondrial transfer mechanisms in immune microenvironment remodeling across diseases
Review explores how cells share mitochondria to influence immune responses in disease
A systematic review summarizes emerging evidence on intercellular mitochondrial transfer mechanisms in inflammation, cancer, and autoimmune …
Cells swap energy factories to reshape immune responses in cancer, inflammation, and autoimmune diseases, offering new ways to target these …
Frontiers
Apr 2, 2026
Oncology
Sys. Review
Hypoxia in solid tumors drives metabolic reprogramming, immune suppression, and therapeutic resistance
How do tumors survive in low oxygen? They completely change how they eat
A systematic review synthesizing evidence on hypoxia in solid tumors found that low oxygen tension orchestrates metabolic reprogramming thro…
When tumors run out of oxygen, they switch diets to eat fat and glutamine, becoming more invasive, acidic, and resistant to treatment.
Frontiers
Apr 2, 2026
Oncology
Report describes COVID-19 deaths among US cancer survivors in 2021
How many cancer survivors died with COVID-19 listed as a cause in 2021?
A descriptive report examined deaths among cancer survivors in the United States during 2021 where COVID-19 was listed as an underlying caus…
A 2021 report confirms COVID-19 was a documented cause of death for some cancer survivors, though it lacks specific numbers or comparisons t…
CDC
Apr 2, 2026
Oncology
Observational study examines cancer death rates by urban-rural status in US population
Do cancer death rates differ between cities and rural areas?
An observational analysis of US National Vital Statistics System data from 1999-2019 examined age-adjusted cancer death rates by urban-rural…
Where you live might play a role in cancer risk, so a new analysis maps death rates across urban and rural areas for men and women over twen…
CDC
Apr 2, 2026
Oncology
Meta-analysis
Low creatinine-cystatin C ratio correlates with reduced survival in cancer patients in meta-analysis
Could a simple blood test ratio help predict cancer survival?
A meta-analysis of 12 observational trials involving 4439 individuals with cancer found a low creatinine-cystatin C ratio (CCR) was correlat…
A low ratio of two kidney markers in blood is linked to shorter survival and higher risk of cancer progression in people with cancer.
Apr 2, 2026